ARCHIVES

New NCI Directory

This article is from The Cancer Letter archive.

Vol. 15 No. 20 | May 19, 1989

Download PDF Visit The Full Archive

Related Articles

NIH Recovery Act Announcements

March 27, 2009

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996